|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases expression multiple interactions |
ISO |
4-nonylphenol results in decreased expression of ABCG2 protein fulvestrant affects the reaction [4-nonylphenol results in decreased expression of ABCG2 protein] |
CTD |
PMID:27036933 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Adam10 |
ADAM metallopeptidase domain 10 |
multiple interactions |
ISO |
ADAM10 protein affects the reaction [[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]] |
CTD |
PMID:28703301 |
|
NCBI chr 8:71,346,008...71,477,889
Ensembl chr 8:71,345,837...71,477,889
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
affects response to substance multiple interactions |
ISO |
ADAM17 protein affects the susceptibility to 4-nonylphenol [ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein; ADAM10 protein affects the reaction [[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein] |
CTD |
PMID:28703301 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
EXP |
4-nonylphenol results in increased expression of ADIPOQ protein |
CTD |
PMID:24388992 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Afap1l2 |
actin filament associated protein 1-like 2 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of AFAP1L2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 1:255,964,238...256,060,828
Ensembl chr 1:255,964,238...256,060,820
|
|
G |
Afp |
alpha-fetoprotein |
affects binding |
EXP |
4-nonylphenol binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects activity affects binding increases activity |
ISO EXP |
4-nonylphenol affects the activity of AHR protein 4-nonylphenol binds to AHR protein 4-nonylphenol results in increased activity of AHR protein |
CTD |
PMID:18294747 PMID:20436506 PMID:28728110 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions decreases expression |
EXP |
4-nonylphenol results in decreased phosphorylation of AKT1 protein [bisphenol A co-treated with 4-nonylphenol] results in increased expression of AKT1 mRNA; Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of AKT1 protein]; bisphenol A inhibits the reaction [4-nonylphenol results in decreased expression of AKT1 mRNA] |
CTD |
PMID:26804764 PMID:30228064 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
increases expression |
EXP |
4-nonylphenol results in increased expression of AKT2 mRNA |
CTD |
PMID:30228064 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Amh |
anti-Mullerian hormone |
decreases expression |
ISO |
4-nonylphenol analog results in decreased expression of AMH mRNA |
CTD |
PMID:27086933 |
|
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
affects expression increases expression |
EXP |
4-nonylphenol affects the expression of APAF1 mRNA 4-nonylphenol results in increased expression of APAF1 protein |
CTD |
PMID:26804764 PMID:27109770 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Ar |
androgen receptor |
affects activity multiple interactions decreases expression |
ISO |
4-nonylphenol affects the activity of AR protein 4-nonylphenol inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] 4-nonylphenol analog results in decreased expression of AR mRNA |
CTD |
PMID:16169144 PMID:18294747 PMID:27086933 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
EXP |
4-nonylphenol results in increased expression of ATG12 mRNA |
CTD |
PMID:28041982 PMID:30228064 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
EXP |
4-nonylphenol results in increased expression of ATG3 mRNA |
CTD |
PMID:28041982 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
EXP |
4-nonylphenol results in increased expression of ATG5 mRNA |
CTD |
PMID:28041982 PMID:30228064 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
increases expression |
EXP |
4-nonylphenol results in increased expression of ATG7 mRNA |
CTD |
PMID:28041982 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr16:18,401,405...18,410,821
Ensembl chr16:18,401,405...18,410,766
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of B4GALT1 mRNA |
CTD |
PMID:14605097 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
EXP |
4-nonylphenol results in increased expression of BAD mRNA; 4-nonylphenol results in increased expression of BAD protein |
CTD |
PMID:26804764 PMID:27087316 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions decreases expression increases expression |
EXP ISO |
3-methyladenine promotes the reaction [4-nonylphenol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BAX protein] 4-nonylphenol results in decreased expression of BAX mRNA; 4-nonylphenol results in decreased expression of BAX protein 4-nonylphenol results in increased expression of BAX mRNA; 4-nonylphenol results in increased expression of BAX protein |
CTD |
PMID:15461258 PMID:26804032 PMID:26804764 PMID:27087316 PMID:27109770 PMID:30228064 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression decreases expression multiple interactions |
ISO EXP |
4-nonylphenol results in increased expression of BCL2 mRNA 4-nonylphenol results in decreased expression of BCL2 mRNA; 4-nonylphenol results in decreased expression of BCL2 protein [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of BCL2 mRNA |
CTD |
PMID:15461258 PMID:26804764 PMID:27087316 PMID:27109770 PMID:30228064 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of BCL2L1 mRNA; 4-nonylphenol results in decreased expression of BCL2L1 protein |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
EXP |
4-nonylphenol results in increased expression of BCL2L11 protein |
CTD |
PMID:26804764 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
EXP |
3-methyladenine inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; AICA ribonucleotide promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein] 4-nonylphenol results in increased expression of BECN1 mRNA; 4-nonylphenol results in increased expression of BECN1 protein |
CTD |
PMID:26804764 PMID:28041982 PMID:30228064 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
4-nonylphenol results in increased cleavage of and results in increased activity of BID protein |
CTD |
PMID:22056370 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Btc |
betacellulin |
multiple interactions |
ISO |
[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein; [RHBDF2 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein; ADAM10 protein affects the reaction [[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein] |
CTD |
PMID:28703301 |
|
NCBI chr14:16,708,447...16,746,961
Ensembl chr14:16,707,982...16,747,049
|
|
G |
Casp1 |
caspase 1 |
increases expression decreases expression |
EXP |
4-nonylphenol results in increased expression of CASP1 mRNA 4-nonylphenol results in decreased expression of CASP1 mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp2 |
caspase 2 |
increases expression |
EXP |
4-nonylphenol results in increased expression of CASP2 mRNA |
CTD |
PMID:27087316 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions affects expression increases expression |
ISO EXP |
4-nonylphenol results in increased cleavage of CASP3 protein 3-methyladenine promotes the reaction [4-nonylphenol results in increased cleavage of CASP3 protein]; 4-nonylphenol results in decreased expression of and results in increased phosphorylation of CASP3 protein; [bisphenol A co-treated with 4-nonylphenol] results in increased expression of CASP3 mRNA; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased cleavage of CASP3 protein]; bisphenol A inhibits the reaction [4-nonylphenol results in increased expression of CASP3 protein modified form] 4-nonylphenol affects the expression of CASP3 mRNA 4-nonylphenol results in increased expression of and results in increased activity of CASP3 protein; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of and results in increased activity of CASP3 protein |
CTD |
PMID:22056370 PMID:26804764 PMID:27109770 PMID:29029336 PMID:30228064 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression |
EXP |
4-nonylphenol results in increased expression of CASP4 mRNA |
CTD |
PMID:27087316 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of CASP6 mRNA |
CTD |
PMID:27109770 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of CASP7 mRNA |
CTD |
PMID:27109770 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases cleavage decreases expression increases expression multiple interactions |
ISO EXP |
4-nonylphenol results in increased cleavage of CASP8 protein 4-nonylphenol results in decreased expression of CASP8 mRNA 4-nonylphenol results in increased expression of CASP8 mRNA 4-nonylphenol affects the reaction [bisphenol A results in increased expression of CASP8 mRNA]; bisphenol A affects the reaction [4-nonylphenol results in increased expression of CASP8 mRNA] |
CTD |
PMID:22056370 PMID:27087316 PMID:30228064 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage increases expression decreases expression |
ISO EXP |
4-nonylphenol results in increased cleavage of CASP9 protein 4-nonylphenol results in increased expression of CASP9 mRNA 4-nonylphenol results in decreased expression of CASP9 mRNA |
CTD |
PMID:22056370 PMID:27087316 PMID:27109770 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of CAT mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of CCBE1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr18:59,579,851...59,823,977
Ensembl chr18:59,580,768...59,824,400
|
|
G |
Ccn5 |
cellular communication network factor 5 |
increases expression multiple interactions |
ISO |
4-nonylphenol results in increased expression of CCN5 mRNA ESR1 protein inhibits the reaction [4-nonylphenol results in increased expression of CCN5 mRNA] |
CTD |
PMID:23384675 |
|
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of CCNA2 protein |
CTD |
PMID:26804764 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
EXP |
4-nonylphenol results in increased expression of CCNB1 protein |
CTD |
PMID:26804764 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression increases expression |
EXP ISO |
4-nonylphenol results in decreased expression of CCND1 protein 4-nonylphenol results in increased expression of CCND1 mRNA; 4-nonylphenol results in increased expression of CCND1 protein |
CTD |
PMID:26804032 PMID:26804764 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of CCNE1 mRNA |
CTD |
PMID:26804032 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression decreases expression |
EXP ISO |
4-nonylphenol results in increased expression of CDKN1A protein 4-nonylphenol results in decreased expression of CDKN1A protein |
CTD |
PMID:26804032 PMID:26804764 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression decreases expression |
EXP ISO |
4-nonylphenol results in increased expression of CDKN1B protein 4-nonylphenol results in decreased expression of CDKN1B mRNA |
CTD |
PMID:26804032 PMID:26804764 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
increases expression |
ISO |
4-nonylphenol results in increased expression of CDKN1C protein |
CTD |
PMID:26027920 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases phosphorylation |
ISO |
4-nonylphenol results in increased phosphorylation of CHEK1 protein |
CTD |
PMID:32466334 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases phosphorylation |
ISO |
4-nonylphenol results in increased phosphorylation of CHEK2 protein |
CTD |
PMID:32466334 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; 4-nonylphenol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]] |
CTD |
PMID:11711029 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:11711029 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:11711029 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; 4-nonylphenol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]] |
CTD |
PMID:11711029 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased phosphorylation of CREB1 protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:23626723 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of CSF1R mRNA |
CTD |
PMID:23626723 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases secretion |
ISO |
4-nonylphenol results in increased secretion of CSF2 protein |
CTD |
PMID:20194071 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
4-nonylphenol results in increased expression of CTSD protein |
CTD |
PMID:26804032 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA 4-nonylphenol results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 protein 4-nonylphenol results in decreased expression of CYP19A1 mRNA; 4-nonylphenol results in decreased expression of CYP19A1 protein |
CTD |
PMID:29029336 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases expression |
ISO |
4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA] 4-nonylphenol results in increased expression of CYP2B6 mRNA 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]; [4-nonylphenol inhibits the reaction [androstan-3-ol binds to and results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA; NR1I3 protein promotes the reaction [4-nonylphenol results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:17483497 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions |
EXP |
4-nonylphenol promotes the reaction [NR1I2 protein results in increased expression of CYP3A23-3A1 mRNA] |
CTD |
PMID:17483497 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DIO2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein] |
CTD |
PMID:23626723 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein] |
CTD |
PMID:23626723 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dnmt3l |
DNA methyltransferase 3 like |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein] |
CTD |
PMID:23626723 |
|
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
|
|
G |
Ebf2 |
EBF transcription factor 2 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of EBF2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr15:41,435,509...41,634,403
Ensembl chr15:41,435,509...41,634,403
|
|
G |
Eeig1 |
estrogen-induced osteoclastogenesis regulator 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of EEIG1 mRNA |
CTD |
PMID:14605097 |
|
NCBI chr 3:15,822,441...15,854,651
Ensembl chr 3:15,823,144...15,854,643
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases phosphorylation multiple interactions |
EXP |
4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:26804764 PMID:28041982 PMID:30228064 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of ERBB2 mRNA |
CTD |
PMID:16393665 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions decreases expression increases activity affects localization affects binding |
ISO EXP |
4-nonylphenol binds to and results in increased activity of ESR1 protein; 4-nonylphenol inhibits the reaction [Estradiol binds to ESR1 protein]; [4-nonylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; ESR1 protein inhibits the reaction [4-nonylphenol results in increased expression of CCN5 mRNA] 4-nonylphenol results in decreased expression of ESR1 mRNA 4-nonylphenol results in increased activity of ESR1 protein; 4-nonylphenol results in increased activity of ESR1 protein mutant form 4-nonylphenol affects the localization of ESR1 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased expression of ESR1 mRNA] 4-nonylphenol binds to ESR1 protein 4-nonylphenol results in decreased expression of ESR1 mRNA; 4-nonylphenol results in decreased expression of ESR1 protein 4-nonylphenol analog results in decreased expression of ESR1 mRNA; 4-nonylphenol analog results in decreased expression of ESR1 protein |
CTD |
PMID:11518614 PMID:11530281 PMID:12127041 PMID:12598185 PMID:16393665 PMID:17141713 PMID:17174995 PMID:19720131 PMID:19913605 PMID:20353888 PMID:20950447 PMID:21783566 PMID:22056370 PMID:23384675 PMID:24388992 PMID:25012808 PMID:27086933 PMID:27633901 PMID:28728110 PMID:29066353 PMID:29162470 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects localization multiple interactions affects binding decreases expression |
ISO |
4-nonylphenol affects the localization of ESR2 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased expression of ESR2 mRNA] 4-nonylphenol binds to and results in increased activity of ESR2 protein; [4-nonylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA 4-nonylphenol binds to ESR2 protein 4-nonylphenol analog results in decreased expression of ESR2 mRNA; 4-nonylphenol analog results in decreased expression of ESR2 protein |
CTD |
PMID:11518614 PMID:12224631 PMID:19913605 PMID:20950447 PMID:21783566 PMID:22056370 PMID:27086933 PMID:27633901 More...
|
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
4-nonylphenol results in increased expression of FAS mRNA; 4-nonylphenol results in increased expression of FAS protein |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
4-nonylphenol results in increased expression of FASLG mRNA; 4-nonylphenol results in increased expression of FASLG protein |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
increases expression |
EXP |
4-nonylphenol results in increased expression of FASN mRNA |
CTD |
PMID:24388992 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of FCGR3A mRNA |
CTD |
PMID:23626723 |
|
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
4-nonylphenol results in increased expression of FOS mRNA; 4-nonylphenol results in increased expression of FOS protein |
CTD |
PMID:24308608 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression multiple interactions |
EXP |
4-nonylphenol results in decreased expression of FSHB protein [4-nonylphenol results in increased susceptibility to bisphenol A] which results in increased secretion of FSHB protein |
CTD |
PMID:27087316 PMID:27109770 PMID:30228064 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gcnt4 |
glucosaminyl (N-acetyl) transferase 4 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of GCNT4 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 2:28,253,325...28,283,082
Ensembl chr 2:28,252,860...28,283,082
|
|
G |
Gh1 |
growth hormone 1 |
increases secretion increases expression multiple interactions |
EXP |
4-nonylphenol results in increased secretion of GH1 protein 4-nonylphenol results in increased expression of GH1 mRNA; 4-nonylphenol results in increased expression of GH1 protein fulvestrant inhibits the reaction [4-nonylphenol results in increased expression of GH1 mRNA]; fulvestrant inhibits the reaction [4-nonylphenol results in increased expression of GH1 protein]; fulvestrant inhibits the reaction [4-nonylphenol results in increased secretion of GH1 protein] |
CTD |
PMID:19145065 PMID:19463694 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of GPER1 mRNA |
CTD |
PMID:29783106 |
|
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of GPX1 mRNA |
CTD |
PMID:27109770 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
ISO |
4-nonylphenol results in increased phosphorylation of H2AX protein |
CTD |
PMID:32466334 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Has2 |
hyaluronan synthase 2 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of HAS2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases secretion multiple interactions |
ISO |
4-nonylphenol results in increased secretion of HBEGF protein 3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amide inhibits the reaction [4-nonylphenol results in increased secretion of HBEGF protein]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]; GW280264X inhibits the reaction [4-nonylphenol results in increased secretion of HBEGF protein] |
CTD |
PMID:28703301 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hoxa1 |
homeobox A1 |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] |
CTD |
PMID:23696197 |
|
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases activity |
ISO |
4-nonylphenol results in decreased activity of HSD11B1 protein |
CTD |
PMID:16184081 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases activity |
ISO |
4-nonylphenol results in decreased activity of HSD11B2 protein |
CTD |
PMID:16184081 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Ifng |
interferon gamma |
affects secretion decreases expression |
ISO EXP |
4-nonylphenol affects the secretion of IFNG protein 4-nonylphenol results in decreased expression of IFNG mRNA |
CTD |
PMID:20194071 PMID:27109770 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
increases secretion |
ISO |
4-nonylphenol results in increased secretion of IL10 protein |
CTD |
PMID:20194071 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
affects secretion affects expression |
ISO EXP |
4-nonylphenol affects the secretion of IL1B protein 4-nonylphenol affects the expression of IL1B mRNA |
CTD |
PMID:20194071 PMID:27109770 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
affects secretion |
ISO |
4-nonylphenol affects the secretion of IL4 protein |
CTD |
PMID:20194071 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
G |
Kcnb2 |
potassium voltage-gated channel subfamily B member 2 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of KCNB2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599
|
|
G |
Kcnv1 |
potassium voltage-gated channel modifier subfamily V member 1 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of KCNV1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 7:76,260,695...76,269,170
Ensembl chr 7:76,260,695...76,269,170
|
|
G |
Klk6 |
kallikrein related-peptidase 6 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of KLK6 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:94,280,340...94,286,121
|
|
G |
Lamp3 |
lysosomal-associated membrane protein 3 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of LAMP3 mRNA |
CTD |
PMID:20678512 |
|
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
|
|
G |
Lep |
leptin |
increases expression |
EXP |
4-nonylphenol results in increased expression of LEP protein |
CTD |
PMID:24388992 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions affects expression decreases expression increases secretion |
EXP |
4-nonylphenol inhibits the reaction [bisphenol A results in increased secretion of LHB protein]; 4-nonylphenol results in decreased expression of and results in decreased secretion of LHB protein; bisphenol A inhibits the reaction [4-nonylphenol results in increased secretion of LHB protein] 4-nonylphenol affects the expression of LHB protein 4-nonylphenol results in decreased expression of LHB protein |
CTD |
PMID:15888928 PMID:17033158 PMID:27087316 PMID:27109770 PMID:30228064 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
increases expression |
EXP |
4-nonylphenol results in increased expression of LPAR3 mRNA |
CTD |
PMID:24460192 |
|
NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357
|
|
G |
Lpl |
lipoprotein lipase |
increases expression |
EXP |
4-nonylphenol results in increased expression of LPL mRNA |
CTD |
PMID:24388992 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Ltf |
lactotransferrin |
multiple interactions |
ISO |
[4-nonylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [4-nonylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA |
CTD |
PMID:21783566 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
increases expression |
EXP |
4-nonylphenol results in increased expression of MAP1LC3A mRNA |
CTD |
PMID:30228064 |
|
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
EXP ISO |
4-nonylphenol results in increased phosphorylation of MAPK1 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]; 4-nonylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; 4-nonylphenol inhibits the reaction [Estrone results in increased phosphorylation of MAPK1 protein]; fulvestrant inhibits the reaction [4-nonylphenol results in increased phosphorylation of MAPK1 protein] 4-nonylphenol analog affects the reaction [Estradiol affects the phosphorylation of MAPK1 protein]; 4-nonylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK1 protein]; 4-nonylphenol analog affects the reaction [Estrone affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:17174995 PMID:19463694 PMID:20870566 PMID:20950447 PMID:28849599 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
EXP ISO |
4-nonylphenol results in increased phosphorylation of MAPK3 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased phosphorylation of MAPK3 protein]; 4-nonylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; 4-nonylphenol inhibits the reaction [Estrone results in increased phosphorylation of MAPK3 protein]; fulvestrant inhibits the reaction [4-nonylphenol results in increased phosphorylation of MAPK3 protein] 4-nonylphenol analog affects the reaction [Estradiol affects the phosphorylation of MAPK3 protein]; 4-nonylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK3 protein]; 4-nonylphenol analog affects the reaction [Estrone affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19463694 PMID:20870566 PMID:20950447 PMID:28849599 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
4-nonylphenol analog results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:27086933 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
4-nonylphenol analog results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:27086933 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of MCL1 protein |
CTD |
PMID:26804764 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation multiple interactions increases phosphorylation |
EXP |
4-nonylphenol results in decreased phosphorylation of MTOR protein 4-nonylphenol inhibits the reaction [bisphenol A results in decreased expression of MTOR mRNA]; 4-nonylphenol inhibits the reaction [bisphenol A results in increased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; AICA ribonucleotide promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; bisphenol A inhibits the reaction [4-nonylphenol results in increased phosphorylation of MTOR protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:26804764 PMID:28041982 PMID:30228064 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Naalad2 |
N-acetylated alpha-linked acidic dipeptidase 2 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:15,406,119...15,479,714
Ensembl chr 8:15,407,043...15,479,714
|
|
G |
Nid1 |
nidogen 1 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NID1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr17:86,085,133...86,158,272
Ensembl chr17:86,085,077...86,158,267
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
affects binding multiple interactions increases activity |
ISO EXP |
4-nonylphenol binds to NR1I2 protein 4-nonylphenol binds to and results in increased activity of NR1I2 protein 4-nonylphenol results in increased activity of NR1I2 protein 4-nonylphenol promotes the reaction [NR1I2 protein results in increased expression of CYP3A23-3A1 mRNA] |
CTD |
PMID:15792627 PMID:17483497 PMID:20869355 PMID:25680588 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity multiple interactions affects localization increases response to substance |
ISO |
4-nonylphenol results in increased activity of NR1I3 protein; 4-nonylphenol results in increased activity of NR1I3 protein alternative form 1,5-benzothiazepine analog inhibits the reaction [4-nonylphenol results in increased activity of NR1I3 protein]; 4-nonylphenol binds to and results in increased activity of NR1I3 protein; 4-nonylphenol binds to and results in increased activity of NR1I3 protein alternative form; 4-nonylphenol inhibits the reaction [PK 11195 results in decreased activity of NR1I3 protein]; 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]; 7-acetoxy-6,7-dihydro-6-(4-methoxyphenyl)pyrrolo(2,1-d)(1,5)benzothiazepine inhibits the reaction [4-nonylphenol results in increased activity of NR1I3 protein]; Clotrimazole inhibits the reaction [4-nonylphenol results in increased activity of NR1I3 protein]; PK 11195 results in decreased susceptibility to [4-nonylphenol binds to and results in increased activity of NR1I3 protein alternative form] 4-nonylphenol affects the localization of NR1I3 protein 4-nonylphenol inhibits the reaction [androstan-3-ol binds to and results in decreased activity of NR1I3 protein]; 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]; [4-nonylphenol inhibits the reaction [androstan-3-ol binds to and results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA; NR1I3 protein promotes the reaction [4-nonylphenol results in increased expression of CYP2B10 mRNA] NR1I3 protein results in increased susceptibility to 4-nonylphenol |
CTD |
PMID:17483497 PMID:20869355 PMID:21227907 PMID:21315811 PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Or10h1d |
olfactory receptor family 10 subfamily H member 1D |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of OR10H1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 7:12,839,664...12,840,620
Ensembl chr 7:12,839,050...12,849,389
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
multiple interactions decreases activity |
EXP |
4-nonylphenol inhibits the reaction [Triiodothyronine, Reverse binds to P4HB protein] 4-nonylphenol results in decreased activity of P4HB protein |
CTD |
PMID:16617682 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression affects expression decreases expression |
ISO EXP |
4-nonylphenol results in increased expression of PCNA mRNA 4-nonylphenol results in increased expression of PCNA protein 4-nonylphenol affects the expression of PCNA mRNA 4-nonylphenol results in decreased expression of PCNA mRNA; 4-nonylphenol results in decreased expression of PCNA protein |
CTD |
PMID:15461258 PMID:18839522 PMID:27087316 PMID:27109770 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of PDZK1 mRNA |
CTD |
PMID:14605097 PMID:16393665 |
|
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Pgr |
progesterone receptor |
increases expression decreases expression |
ISO EXP |
4-nonylphenol results in increased expression of PGR mRNA 4-nonylphenol analog results in decreased expression of PGR mRNA |
CTD |
PMID:16393665 PMID:17033158 PMID:27086933 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
increases expression multiple interactions |
EXP |
4-nonylphenol results in increased expression of PIK3CG mRNA 4-nonylphenol promotes the reaction [bisphenol A results in increased expression of PIK3CG mRNA]; bisphenol A promotes the reaction [4-nonylphenol results in increased expression of PIK3CG mRNA] |
CTD |
PMID:30228064 |
|
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of POU5F1 mRNA |
CTD |
PMID:20615461 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression |
EXP |
4-nonylphenol results in increased expression of PPARG mRNA |
CTD |
PMID:24388992 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppfia4 |
PTPRF interacting protein alpha 4 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of PPFIA4 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
EXP |
PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein] |
CTD |
PMID:28041982 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
EXP |
[4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA; [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of PRKAA2 mRNA |
CTD |
PMID:30228064 |
|
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Prl |
prolactin |
increases expression multiple interactions increases secretion |
EXP ISO |
4-nonylphenol results in increased expression of PRL mRNA fulvestrant inhibits the reaction [4-nonylphenol results in increased expression of PRL mRNA]; fulvestrant inhibits the reaction [4-nonylphenol results in increased secretion of PRL protein] 4-nonylphenol affects the reaction [Estriol results in increased secretion of PRL protein]; 4-nonylphenol inhibits the reaction [Estradiol results in increased secretion of PRL protein]; 4-nonylphenol inhibits the reaction [Estrone results in increased secretion of PRL protein] |
CTD |
PMID:17174995 PMID:19463694 PMID:20950447 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Pten |
phosphatase and tensin homolog |
decreases phosphorylation increases expression multiple interactions |
EXP |
4-nonylphenol results in decreased phosphorylation of PTEN protein 4-nonylphenol results in increased expression of PTEN mRNA 4-nonylphenol promotes the reaction [bisphenol A results in decreased phosphorylation of PTEN protein]; bisphenol A inhibits the reaction [4-nonylphenol results in decreased phosphorylation of PTEN protein] |
CTD |
PMID:30228064 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Rhbdf2 |
rhomboid 5 homolog 2 |
multiple interactions affects response to substance |
ISO |
[RHBDF2 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein |
CTD |
PMID:28703301 |
|
NCBI chr10:101,833,157...101,860,283
Ensembl chr10:101,833,157...101,860,283
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions decreases phosphorylation |
EXP |
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:26804764 PMID:28041982 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rxra |
retinoid X receptor alpha |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of RXRA mRNA |
CTD |
PMID:16013040 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
S100g |
S100 calcium binding protein G |
increases expression |
EXP |
4-nonylphenol results in increased expression of S100G mRNA; 4-nonylphenol results in increased expression of S100G protein |
CTD |
PMID:17365578 |
|
NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433
|
|
G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of SBSPON mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 5:3,402,763...3,433,338
Ensembl chr 5:3,402,648...3,435,420
|
|
G |
Sdr16c5 |
short chain dehydrogenase/reductase family 16C, member 5 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of SDR16C5 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 5:17,018,813...17,043,974
Ensembl chr 5:17,018,813...17,040,970
|
|
G |
Serf1 |
small EDRK-rich factor 1 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of SERF1A mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 2:31,475,902...31,482,030
Ensembl chr 2:31,475,703...31,482,032
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
4-nonylphenol binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Skil |
SKI-like proto-oncogene |
increases expression |
ISO |
4-nonylphenol results in increased expression of SKIL protein |
CTD |
PMID:24308608 |
|
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
|
|
G |
Slc7a7 |
solute carrier family 7 member 7 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of SLC7A7 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions decreases phosphorylation |
ISO |
fulvestrant inhibits the reaction [4-nonylphenol results in decreased phosphorylation of SMAD3 protein] |
CTD |
PMID:24308608 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of SOD1 mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of SP1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
EXP |
4-nonylphenol results in increased expression of SREBF1 mRNA |
CTD |
PMID:24388992 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of STAR mRNA |
CTD |
PMID:29029336 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
increases metabolic processing |
ISO |
SULT1A1 protein results in increased metabolism of 4-nonylphenol |
CTD |
PMID:10623578 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult1b1 |
sulfotransferase family 1B member 1 |
increases metabolic processing |
ISO |
SULT1B1 protein results in increased metabolism of 4-nonylphenol |
CTD |
PMID:10623578 |
|
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Progesterone results in increased expression of SULT1E1 mRNA] |
CTD |
PMID:22414680 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
increases metabolic processing |
ISO |
SULT2A1 protein results in increased metabolism of 4-nonylphenol |
CTD |
PMID:10623578 |
|
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tf |
transferrin |
increases expression |
ISO |
4-nonylphenol analog results in increased expression of TRF mRNA |
CTD |
PMID:27086933 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of TFF1 mRNA |
CTD |
PMID:16393665 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions increases secretion |
ISO |
ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]; GW280264X inhibits the reaction [4-nonylphenol results in increased secretion of TGFA protein] |
CTD |
PMID:28703301 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Triiodothyronine results in increased activity of THRB protein] |
CTD |
PMID:31077750 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tnf |
tumor necrosis factor |
affects secretion increases expression decreases expression |
ISO EXP |
4-nonylphenol affects the secretion of TNF protein 4-nonylphenol results in increased expression of TNF mRNA; 4-nonylphenol results in increased expression of TNF protein 4-nonylphenol results in decreased expression of TNF protein |
CTD |
PMID:20194071 PMID:27109770 PMID:28490175 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression increases phosphorylation |
EXP ISO |
4-nonylphenol results in increased expression of TP53 mRNA; 4-nonylphenol results in increased expression of TP53 protein 4-nonylphenol results in increased phosphorylation of TP53 protein |
CTD |
PMID:27087316 PMID:27109770 PMID:32466334 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trmt9b |
tRNA methyltransferase 9B (putative) |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of TRMT9B mRNA |
CTD |
PMID:23626723 |
|
NCBI chr16:55,740,551...55,792,198
Ensembl chr16:55,743,018...55,792,144
|
|
G |
Tsc2 |
TSC complex subunit 2 |
decreases phosphorylation multiple interactions |
EXP |
4-nonylphenol results in decreased phosphorylation of TSC2 protein dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of TSC2 protein] |
CTD |
PMID:26804764 PMID:28041982 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Ttr |
transthyretin |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Thyroxine binds to TTR protein] |
CTD |
PMID:31077750 |
|
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Vipr1 |
vasoactive intestinal peptide receptor 1 |
multiple interactions |
ISO |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of VIPR1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
|
|